CIPROFLOXACIN INTRAVENOUS INFUSION BP
SANDOZ CANADA INCORPORATED
Quick answers
Is there a shortage of CIPROFLOXACIN INTRAVENOUS INFUSION BP in Canada?
No. There is no current shortage of CIPROFLOXACIN INTRAVENOUS INFUSION BP 2MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SANDOZ CIPROFLOXACIN
SANDOZ CANADA INCORPORATED
RIVA-CIPROFLOXACIN
LABORATOIRE RIVA INC.
JAMP-CIPROFLOXACIN
JAMP PHARMA CORPORATION
CIPROFLOXACIN
SANIS HEALTH INC
MAR-CIPROFLOXACIN
MARCAN PHARMACEUTICALS INC
ACT CIPROFLOXACIN
TEVA CANADA LIMITED
DIN
02304759
Strength
2MG
Dosage Form
SOLUTION
Route
INTRAVENOUS
Compare with another product →
Shortage History
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759